129 related articles for article (PubMed ID: 26229429)
21. Erratum to: Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma.
Mizoue S; Nitta K; Shirakashi M; Nitta A; Yamabayashi S; Kimura T; Ueda T; Takeda R; Matsumoto S; Yoshikawa K
Adv Ther; 2017 Sep; 34(9):2179. PubMed ID: 28856599
[No Abstract] [Full Text] [Related]
22. Erratum: Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum].
Onco Targets Ther; 2017; 10():1709. PubMed ID: 28356758
[TBL] [Abstract][Full Text] [Related]
23. Erratum: Short wave-automated perimetry (SWAP) versus optical coherence tomography in early detection of glaucoma [Corrigendum].
Clin Ophthalmol; 2018; 12():2313. PubMed ID: 30518995
[TBL] [Abstract][Full Text] [Related]
24. Erratum: Burden of comorbidities among Japanese patients with atrial fibrillation: a case study of dyspepsia [Corrigendum].
Clin Exp Gastroenterol; 2013; 6():193. PubMed ID: 24098088
[TBL] [Abstract][Full Text] [Related]
25. Erratum: Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2018; 13():3587. PubMed ID: 30464440
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis.
Liu Y; Zhao J; Zhong X; Wei Q; Huang Y
Front Pharmacol; 2019; 10():679. PubMed ID: 31293419
[No Abstract] [Full Text] [Related]
27. Response to Chua et al. re: "The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study".
Jin SW
J Ocul Pharmacol Ther; 2019; 35(1):5. PubMed ID: 30699062
[No Abstract] [Full Text] [Related]
28. Effect of brimonidine on intraocular pressure in normal tension glaucoma: a short term clinical trial.
Gandolfi SA; Cimino L; Mora P
Eur J Ophthalmol; 2003; 13(7):611-5. PubMed ID: 14552594
[TBL] [Abstract][Full Text] [Related]
29. Erratum: Confirmation of the factorial structure of the Japanese short version of the TEMPS-A in psychiatric patients and general adults [Corrigendum].
Neuropsychiatr Dis Treat; 2017; 13():767-768. PubMed ID: 28331327
[TBL] [Abstract][Full Text] [Related]
30. Re: "The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study" by Jin and Lee (J. Ocul. Pharmacol. Ther. 34:274-279, 2018).
Chua PY; Clare G; Leslie T
J Ocul Pharmacol Ther; 2019; 35(1):3-4. PubMed ID: 30699063
[No Abstract] [Full Text] [Related]
31. Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation.
Lusthaus JA; Goldberg I
Expert Opin Drug Saf; 2017 Sep; 16(9):1071-1078. PubMed ID: 28656780
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the clinical success rates and quality of life effects of brimonidine tartrate 0.2% and betaxolol 0.25% suspension in patients with open-angle glaucoma and ocular hypertension. Brimonidine Outcomes Study Group II.
Javitt J; Goldberg I
J Glaucoma; 2000 Oct; 9(5):398-408. PubMed ID: 11039742
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the comfort of Alphagan P compared with Alphagan in irritated eyes.
Mundorf T; Wilcox KA; Ousler GW; Welch D; Abelson MB
Adv Ther; 2003; 20(6):329-36. PubMed ID: 15058750
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5% timolol in normal-tension glaucoma patients.
Kim JM; Kim TW; Kim CY; Kim HK; Park KH
Jpn J Ophthalmol; 2016 Jan; 60(1):20-6. PubMed ID: 26578422
[TBL] [Abstract][Full Text] [Related]
35. Erratum: Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum].
Clin Ophthalmol; 2017; 11():619. PubMed ID: 28435211
[TBL] [Abstract][Full Text] [Related]
36. Erratum: Safety and efficacy of an add-on therapy with curcumin phytosome and piperine and/or lipoic acid in subjects with a diagnosis of peripheral neuropathy treated with dexibuprofen [Erratum].
J Pain Res; 2013; 6():641. PubMed ID: 24009429
[TBL] [Abstract][Full Text] [Related]
37. Erratum: Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate-severe Gram-positive infections [Corrigendum].
Infect Drug Resist; 2019; 12():431. PubMed ID: 30863125
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma.
Fung AT; Reid SE; Jones MP; Healey PR; McCluskey PJ; Craig JC
Br J Ophthalmol; 2007 Jan; 91(1):62-8. PubMed ID: 16956912
[TBL] [Abstract][Full Text] [Related]
39. Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients. Brimonidine Study Group.
Katz LJ
Am J Ophthalmol; 1999 Jan; 127(1):20-6. PubMed ID: 9932994
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of brimonidine in preventing intraocular pressure spikes following phacoemulsification in glaucoma patients.
Kandarakis A; Soumplis V; Karampelas M; Panos C; Kyriakos N; Baxevanakis A; Karagiannis D
Eur J Ophthalmol; 2010; 20(6):994-9. PubMed ID: 20544673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
